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The long bones of vertebrate limbs form by endochondral ossification, whereby
mesenchymal cells differentiate into chondrogenic progenitors, which then differentiate
into chondrocytes. Chondrocytes undergo further differentiation from proliferating to
prehypertrophic, and finally to hypertrophic chondrocytes. Several signaling pathways
and transcription factors regulate this process. Previously, we and others have shown
in chicken that overexpression of an activated form of Calcium/calmodulin-dependent
kinase II (CaMKII) results in ectopic chondrocyte maturation. Here, we show that this is
not the case in the mouse. Although, in vitro Mef2c activity was upregulated by about
55-fold in response to expression of an activated form of CaMKII (DACaMKII), transgenic
mice that expressed a dominant-active form of CaMKII under the control of the Col2a1
regulatory elements display only a very transient and mild phenotype. Here, only the
onset of chondrocyte hypertrophy at E12.5 is accelerated. It is also this early step in
chondrocyte differentiation that is temporarily delayed around E13.5 in transgenic mice
expressing the peptide inhibitor CaM-KIIN from rat (rKIIN) under the control of the Col2a1
regulatory elements. Yet, ultimately DACaMKII, as well as rKIIN transgenic mice are born
with completely normal skeletal elements with regard to their length and growth plate
organization. Hence, our in vivo analysis suggests that CaMKII signaling plays a minor
role in chondrocyte maturation in mice.
Keywords: CaMKII, peptide inhibitor, chondrocyte maturation, hypertrophy, Mef2c, mouse model
INTRODUCTION
Endochondral ossification is the process underlying the formation of the long bones in the
vertebrate limbs (Erlebacher et al., 1995; Kronenberg, 2003). It starts with the condensation
of mesenchymal cells that undergo chondrogenic differentiation, forming a cartilage template
consisting of immature chondrocytes. These produce an extracellular matrix composed of
proteoglycans, glycosaminoglycans, and glycoproteins. This template, which prefigures the
future skeletal element, enlarges through chondrocyte proliferation (Akiyama and Lefebvre,
2011). In the next phase, chondrocytes in the center of the cartilage anlage stop proliferating
and differentiate into prehypertrophic, Indian hedgehog (Ihh) expressing chondrocytes.
Prehypertrophic chondrocytes enlarge further, becoming hypertrophic chondrocytes, which
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initiate synthesis of extracellular matrix containing type
X collagen, encoded by the Col10a1 and Col10a2 genes
(Kronenberg, 2003). The transition of chondrocytes from
proliferating to prehypertrophic and then to hypertrophic cells is
a critical step in determining the growth rate and size of skeletal
elements (Kronenberg, 2003).
Previous studies in chicken and mouse identified a complex
network of signaling pathways and transcription factors
that regulate the different steps during endochondral bone
formation (reviewed in Karsenty, 2008; Hartmann, 2009;
Lefebvre and Bhattaram, 2010). A central regulatory node
in the chondrocyte differentiation program is the Ihh-
PTHrP (parathyroid hormone-related peptide) feedback
loop (Vortkamp et al., 1996). Ihh, which is part of this feedback
loop, is considered a master regulator of chondrocyte maturation
and has multiple functions (Kronenberg, 2003; Mak et al.,
2008). Numerous transcription factors such as Runx2 and
Runx3, Mef2c, and Mef2d, as well as transcriptional co-
factors such as β-catenin, promote chondrocyte hypertrophy
(Inada et al., 1999; Kim et al., 1999; Hartmann and Tabin,
2000; Yoshida et al., 2004; Arnold et al., 2007; Guo et al.,
2009).
It is not yet well established how the activity of these
transcription factors is regulated by signaling events.
Ca2+/calmodulin-dependent kinase II (CaMKII), is a calmodulin
(CaM) binding serine/threonine kinase and important for
Ca2+-mediated signal transduction (Colbran et al., 1989).
Most vertebrates possess four different CaMKII genes (α, β,
γ, and δ) giving rise to at least 38 different splice variants
(Tombes et al., 2003). Two hallmarks distinguish CaMKII
from other kinases: firstly, it acts as a multimeric holoenzyme
composed of 4–14 heteromeric or homomeric subunits of
the different isoforms of the four genes and secondly, its
ability to autophosphorylate on the threonine 286 residue
upon Ca2+/CaM binding (Soderling, 1996; Hudmon and
Schulman, 2002; Colbran, 2004; Lantsman and Tombes, 2005;
Rosenberg et al., 2006). Autophosphorylation relieves the
enzyme from its Ca2+/CaM dependence. Alternatively, CaMKII
can be activated by methionine oxidation (Erickson et al.,
2008).
Various studies suggest that CaMKII signaling may play a
role in skeletogenesis. All four genes are expressed in chicken
and mouse chondrocytes (Taschner et al., 2008; Li and Dudley,
2009). Studies on human articular chondrocytes have suggested
that CaMKII is involved in N-methyl-D-Aspartic acid (NMDA)
receptor signaling, which is important for maintaining matrix
integrity of joints (Salter et al., 2004; Shimazaki et al., 2006).
CaMKII signaling has also been implicated in osteoblast and
osteoclast differentiation (Quinn et al., 2000; Zayzafoon et al.,
2005). In the chicken, we demonstrated previously using a
retroviral system that the expression of a dominant active form
of CaMKII (DaCaMKII), which mimics the autophosphorylated
form, caused premature ectopic chondrocyte maturation, while
the inhibition of CaMKII activity by a peptide inhibitor (rKIIN)
Abbreviations: CaMKII, Calcium/calmodulin-dependent kinase II; Gfp, Green
fluorescent protein; ISH, in situ hybridizations; tg, transgenic; E, embryonic day.
delayed the hypertrophic program (Taschner et al., 2008). Li
and colleagues suggested that the increasing CaMKII activity in
the chondrocytes during their transition from the proliferative
to the prehypertrophic state regulates Runx2 and β-catenin
activity and thereby promotes chondrocyte hypertrophy (Li et al.,
2011).
Retroviral driven expression in the chick system has the
disadvantage that all mitotically active cells get infected. So
besides the chondrocytes also the soft-tissue is infected. This
makes it difficult to distinguish between cell-autonomous and
non-cell-autonomous effects. Using a transgene approach in the
mouse allowed us to overcome this problem. Hence, in order to
gain more specific insights into the potential role of CaMKII in
endochondral bone formation, we expressed an activated form
of CaMKII (DaCaMKII) or the peptide inhibitor rKIIN under
the control of the Col2a1 promoter primarily in chondrocytes.
Based on our observations in the transgenic mouse models we
conclude that modulation of CaMKII activity in the mouse has
only an effect early in development at the onset of chondrocyte
hypertrophy.
MATERIALS AND METHODS
Generation of Col2a1-Transgenic Mice
For the dominant active CaMKII transgene a cassette containing
CaMKII-T286D C-terminal fused to eGFP (Taschner et al.,
2008) followed at the 3′ end by two SV40polyA sequences was
inserted via blunt-end cloning into the BamHI site of a plasmid
carrying the Col2a1 promoter–rabbit β globin intron–Col2a1
enhancer element (a gift from Yoshi Yamada; (Nakata et al.,
1993)). For the rKIIN transgene, a peptide inhibitor for CaMKII
from rat (Chang et al., 1998, 2001) fused with eGFP at its N-
terminus (Taschner et al., 2008) was cloned accordingly. The
final transgenic constructs (Figures 1A,B) were excised with
the restriction enzymes AfllII and SwaI, purified on agarose
gel and eluted with DNA microinjection buffer. The linear
transgene cassettes were microinjected into the pronucleus of
B6CBAF1 zygotes in the transgene facility of the IMP, Vienna,
Austria (Hogan et al., 1994). The zygotes were implanted into
pseudo-pregnant mice to obtain transgenic founder lines. To
maintain the transgenic lines in a pure genetic background,
the founder lines were crossed with C57Bl/6J females and the
subsequent generations were backcrossed with C57Bl/6J animals
over at least eight generations. Genotyping of transgenic mice
and embryos was performed by PCR using ear biopsies and
material from the embryonic tail respectively, in combination
with transgene-specific primer pairs (listed in Supplementary
Table 1). Transgene-copy numbers were determined using
genomic DNA from ear biopsies of the different transgenic lines
(two independent samples per line) by qPCR and normalized
to actin and control genomic DNA from mice carrying one
copy of the transgene in the Rosa26 locus (Amara and
Hartmann, unpublished; Ballester et al., 2004). Primers are
listed in Supplementary Table 2. Mouse experiments were
performed in accordance with local, institutional and national
regulations under the following licenses (84-02.05.2012.260, 84-
02.04.2015.A278, 84-02.05.50.15.022).
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FIGURE 1 | CaMKII activity translocates β-catenin into the nucleus and regulates Runx2 and Mef2c activity in a dose dependent manner. (A) qPCR
showing the expression levels of the four Camk2 isoforms, α, β, γ, δ, in chondrocytes isolated from E12.5 skeletal elements. Expression levels were normalized to
Gapdh and Actb and ploted relative to the expression of CaMKIIγ. n = 3. Error bars indicate ±SEM. (B) Epiphyseal chondrocytes from P6 wild-type limbs were
transfected with an expression vector encoding DaCaMKII::eGFP or eGFP (control). Nuclear localization of β-catenin (white arrows) was observed in DaCaMKII
transfected cells. (C) Primary chondrocytes from E13.5 appendicular skeletal elements were co-transfected with 6X Ose2 luciferase (OSE2-luc) reporter and TK-renilla
reporter plus increasing amounts of the expression vector encoding DaCaMKII or rKIIN. Ratios of luciferase activity with respect to control (Ctrl, black bar) are plotted
as bar charts: DaCaMKII (green bars) and rKIIN (red bars). (D) Relative Runx2 expression levels, determined by qPCR, in primary chondrocytes from E13.5
appendicular skeletal elements co-transfected with increasing amounts of an expression vector encoding DaCaMKII or rKIIN used for the OSE2-Luc assay.
(E) Primary chondrocytes from E13.5 wild-type appendicular skeletal elements were co-transfected with 3X Mef2 luciferase reporter (MEF2-Luc), TK-renilla reporter,
and increasing amounts of the expression vector encoding DaCaMKII or rKIIN. Bar graph showing the ratio of luciferase activity with respect to control (Ctrl, black bar),
DaCaMKII (green bars), and rKIIN (red bars) from four independent transfection experiments. The immunoblot below shows the corresponding increase in CaMKII
levels. (F) Relative Mef2c expression levels, determined by qPCR, in primary chondrocytes from MEF2-luc assays co-transfected with increasing amounts of
expression vector encoding DaCaMKII or rKIIN. *p < 0.05, **p < 0.01, ***p < 0.001, n.s., not significant. Error bars indicate ± SEM.
Mouse Husbandry and Embryo Processing
For timed pregnancies, heterozygous transgenic mice were
interbred overnight and the plug day was designated as
embryonic day 0.5 (E0.5). Embryos were harvested at
the required stages, dissected and fixed overnight in 4%
paraformaldehyde (PFA). For stages E18.5 and older, the skin
above the limbs was removed prior to fixation. Fixed limbs
were removed, washed in PBS, and tissue was dehydrated using
increasing ethanol concentrations (25, 50, 75, 100%).
In situ Hybridization, Histology and
Skeletal Preparations
For in situ hybridization (ISH) and histological staining on
sections, limbs were processed into paraffin using the Excelsior
ES Vacuum Infiltration Processor (Thermo Scientific), embedded
in paraffin and sectioned at 5 µm. Non-radioactive ISH were
performed using digoxigenin (DIG)-labeled anti-sense RNA
probes as previously described (Murtaugh et al., 2001). Probes
for type 2 collagen (Col2a1), indian hedgehog (Ihh), osteocalcin
(Ocn), osteopontin (Opn), type 1 collagen (Col1a1), and type 10
collagen (Col10a1) have been published previously (Hill et al.,
2005). The Gfp probe was generated using a plasmid containing
the eGFP coding region. All probes are available upon request.
Histological stainings such as alcian blue, alcian blue/von Kossa,
and hematoxylin/eosin were performed as previously described
(Houben et al., 2016). Skeletal preparations were performed on
6 day old pups which were sacrificed by decapitation, skinned,
eviscerated, fixed in 95% EtOH, and double-stained for alcian
blue and alizarin red (McLeod, 1980). The length of isolated
humeri and femora was calculated by using Zeiss image analysis
software.
RNA Isolation and qPCR
The stylo- and zeugopod regions of forelimbs were isolated from
embryos at the required stage. Skin and soft tissue was removed
and skeletal elements were dispersed using the Polytron PT
1200 E manual disperser with the aggregate PT-DA 03/2 EC-E50
(Kinematica). The RNA was isolated using the QIAGEN RNeasy
micro kit according to the manufacturer’s instructions. A total
of 500 ng RNA was reverse transcribed using PrimeScript RT
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reagent kit (Takara, #RR037A) with oligo dT primer. For qPCR
cDNA was diluted 1:10 in water. 3µl of diluted cDNA were
mixed with 1µl of primer mix and 10µl SYBR Premix Ex TaqII
(Tli RNaseH plus) (Takara, #RR820Q) in a final volume of 20µl.
Gene expression was monitored using the BioRad CFX96 cycler
and the following protocol: 95◦C 10 min, 45 × (95◦C 30 s, 60◦C
30 s, 72◦C 45 s + plate read), 72◦C 5 min, melting curve: 55◦C–
99◦C in 0.5◦C increments for 5 s+ plate read. qPCR analysis was
performed in duplicates and results were produced from at least
three independent samples. Expression values were calculated
using the comparative 1C(t) method and normalized to Gapdh
and Actb expression. For primer sequences and product sizes see
Supplementary Table 3.
Isolation and Cultivation of Primary
Chondrocytes
E13.5 appendicular skeletal elements from the stylo- and
zeugopod were dissected in PBS supplemented with 1% P/S
followed by a digestion with 0.1% type II collagenase (Gibco,
#17101-015) and 0.3% dispase (Gibco, #17105-041) in medium
(DMEM/F-12; 1% P/S) for a period of 60 min shaking at 100 rpm
in a CO2 incubator. Cells were filtered through a cell strainer,
centrifuged and washed with culture medium (DMEM/F-12, 1%
P/S, and 10% FCS). Cell pellets were then resuspended in culture
medium, plated at 2.5–3 × 104 cells/cm2 in tissue culture flasks
and grown for 5 days.
Luciferase Assays
Primary chondrocytes were seeded at a density of 3 × 104
cells/well in 48 well plates 1 day prior to transfection. Cells
were transfected with the pGL4.23-Mef2-luc (a gift from
Eric Olson) or the pGL4.10-Ose2-luc reporter plasmid (a gift
from G. Karsenty) in combination with pRL-TK (Promega)
as a control and pCDNA3.1-DaCaMKII or pCDNA3.1-rKIIN
expression vectors. Total amounts of transfected plasmids
(equivalent to 52 fM) in each group were adjusted by adding
empty vector (pCDNA3.1+). Transfection was performed using
jetPRIMETM (Polyplus transfection) according to manufacturer’s
instructions. Luciferase activities were measured 48 h after
transfection following the protocol by (Hampf and Gossen,
2006). Luciferase measurements were normalized to the
corresponding renilla activities for transfection efficiency.
Experiments were performed in triplicates and repeated at least
three times.
Immunofluorescence
For immunofluorescent staining on cells, primary chondrocytes
isolated from P6 C57Bl/6J knee epiphyseal regions were
seeded on 0.1% gelatin coated glass coverslips. Cells were
transfected with DaCaMKII::eGFP and eGFP expression
vectors (equivalent to 0.12 pmol) using jetPRIMETM (Polyplus
transfection). Forty-Eight hours after transfection, cells
were fixed with 4% PFA/PBS for 20 min, treated with 0.5%
TritonX-100 for 5 min and blocked with 10% normal goat
serum (NGS) in PBS for 1 h at room temperature (RT).
Incubation with β-catenin antibody (1:200 in 2% NGS/PBS,
BD Biosciences, #610154, RRID:AB_397555) was performed
overnight at 4◦C. Coverslips were subsequently incubated
with Alexa Fluor 647 goat anti-mouse IgG (Molecular Probes)
at 1:200 in 2% NGS/PBS. Nuclei were counterstained with
DAPI.
Immunoprecipitation by Magnetic Beads
HEK293 cells were co-transfected with Mef2c-Myc and
DaCaMKII::eGFP at 4:3 ratio or FLAG-HDAC4 and
DaCaMKII::eGFP at 1:3 ratio using CaPO4 transfection
method. Cells were lysed in ice-cold lysis buffer (50 mM Tris-
HCl pH 7.5, 150 mM NaCl, 1% NP-40 with proteinase and
phosphatase inhibitors). After centrifugation, a total amount
of 150 µg of protein from the supernatant was subjected to
immunoprecipitation using 25µl magnetic beads coupled
with GFP monoclonal antibody (MBL, #D153-11) under the
following conditions: 15 min at 4◦C on a rotating wheel (10
rpm), washed 4 times with wash buffer (50 mM Tris-HCl pH 7.5,
150 mM NaCl, 1% NP-40) for 5min at RT. For the pull-down
of FLAG-HDAC4 using GFP-magnetic beads the conditions
were as following: 500µg of protein from the supernatant was
subjected to immunoprecipitation using 50 µl magnetic beads
and bound for 45 min at 4◦C on a rotating wheel (10 rpm),
followed by 3 washes (50 mM Tris-HCl pH 7.5, 150 mM NaCl,
0.05% NP-40) for 30 s at RT. Magnetic beads were then boiled
for 2 min in 25 µl Laemmli’s sample buffer and supernatant
of the beads was loaded on a 10% SDS-PAGE to separate the
immunoprecipitated proteins.
Immunoblots
Transfected primary chondrocytes were lysed with ice-cold lysis
buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% NP-40 with
proteinase and phosphatase inhibitors). 50µg of protein lysates
were run on a 10% SDS-PAGE and transferred to a 0.45 µm
PVDF-membrane by semi-dry transfer (PerfectBlueTM, PeqLab).
The membrane was blocked with 5% milk and incubated
with the appropriate primary antibodies anti-GFP (1:15000,
Abcam, #ab13970, RRID:AB_300798), anti-Myc (1:1000, Cell
Signaling Technology, mAb #2276, RRID:AB_331783), pan-
CaMKII (1:1000, Cell Signaling Technology, mAb #4436S,
RRID:AB_10545451), anti-Flag (1:1000, Sigma-Aldrich, #F1804,
RRID:AB_262044), and proteasome 20 (P20) (1:15000, Abcam,
#ab3325, RRID:AB_303706), followed by incubation with
the respective, species-specific HRP-coupled secondary
antibodies (1:1000 and 1:5000). ECL substrate was used for
signal development (Amersham, #RPN2106) on X-ray film
(Amersham).
Image Acquisition
Histological images were acquired using Zeiss AxioImager
M2 equipped with an AxioCam MRc 6.45µm color camera
(Zeiss, Jena). Images of embryos were acquired using a Zeiss
Stereo discovery V8 equipped with Zeiss plan Apo S, 0.63X
lens. Immunofluorescent images were acquired using Zeiss
AxioImager M2 equipped with an Apotome2 and an AxioCam
MRm 6.45µm monochromatic camera (Zeiss, Jena) using the
Zen software (Zeiss, Jena).
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Statistical Analysis
All statistical analyses were performed using GraphPad Prism
software 6.0 (RRID: SCR_002798). Data are displayed as
mean values ± standard error of the mean (SEM). Statistical
significance of differences (P-value) was determined by the two-
tailed, unpaired Student’s t-test.
RESULTS
In Vitro: CaMKII Signaling Affects
β-Catenin Localization and Alters Runx2
and Mef2c Activity
Based on previous studies in chicken, potential molecular
mechanisms of how CaMKII signaling regulates chondrocyte
hypertrophy have been suggested (Li et al., 2011). These
included increased nuclear localization of β-catenin and Runx2
in chondrocytes with activated CaMKII signaling (Li et al., 2011).
Thus, we investigated whether the molecular mechanism in
mouse chondrocytes may be similar. Mouse chondrocytes, like
chicken chondrocytes, express all four CaMKII isoforms, and also
here the CaMKIIβ isoform was expressed at lower levels than the
other three isoforms (Figure 1A, see also Taschner et al., 2008; Li
et al., 2011). Similar to what was observed in chicken, β-catenin
was localized in the nucleus in mouse chondrocytes transfected
with a DaCaMKII::GFP expression plasmid (Figure 1B, white
arrows). This was not observed in the GFP-transfected control
cultures (Figure 1B, left panel). We also analyzed whether Runx2
transcriptional activity was altered by the presence of DaCaMKII
or rKIIN in mouse chondrocytes. For this, the Runx2-dependent
OSE2-luc reporter (Ducy and Karsenty, 1995) was co-transfected
into primary chondrocytes with increasing amounts of either
DaCaMKII or rKIIN expression plasmid. OSE2-luc reporter
activity was upregulated in response to increasing amounts of
DaCaMKII, while expression of rKIIN led to a downregulation
of the reporter activity in a concentration independent manner
(Figure 1C). To rule out the possiblity that modulation of
CaMKII activity affects the expression levels of Runx2 itself, we
examined the Runx2 expression levels in the OSE2-luc assay
by qPCR. Here, Runx2 expression was not affected in cells
transfected with the DaCaMKII or rKIIN expression plasmids
(Figure 1D).
Another transcription factor promoting hypertrophy is
Mef2c (Arnold et al., 2007). The MEF2-luc reporter (Naya
et al., 1999) was activated over 50-fold by DaCaMKII at
the highest concentration used (Figure 1E). An increase in
CaMKII protein levels corresponding to the increased amount
of transfected expression plasmid was demonstrated by western
blot (Figure 1E, lower panel). The DaCaMKII expression levels
were also determined by qPCR using a primer that detects the
mouse as well as the transgenic rat Camk2a transcript. Here, the
Camk2a expression levels were normalized to the endogenous
Camk2a expression levels in control-transfected chondrocytes.
This quantitative approach revealed an over 100-fold increase
in Camk2a levels the cells transfected with 30 fM DaCaMKII
(Supplementary Figure 1). Overexpression of rKIIN on the other
hand, led, with the exception of the highest concentration, to a
downregulation of the MEF2-luc reporter activity independent
of the concentration (Figure 1E). To our surprise, at the
highest concentration even a two-fold activation was observed
(Figure 1E). Again, the endogenous Mef2c expression levels
were not significantly affected by either DaCaMKII or rKIIN
expression in the transfected primary chondrocytes (Figure 1F).
Given the strong effect on Mef2c activity we tested whether
CaMKII may directly interact with Mef2c. Co-immunopre-
cipitation assays in HEK293 cells using tagged proteins revealed
that the activated form of CaMKII physically interacts withMef2c
(Figure 2A). Here we used GFP-magnetic beads and pulled
on the DaCaMKII::GFP fusion protein and detected bound
Mef2c::Myc (Figure 2A). Conversely, using Myc-magnetic beads
and pulling on Mef2c::Myc the DaCaMKII::GFP fusion protein
was detected by immunoblot in the bound fraction (data not
shown).
Given previous findings that (a) the CaMKIIδ isoform can
interact with and influence histone deacetylase 4 (Hdac4) activity
in cardiomyocyte hypertrophy (Backs et al., 2006, 2009), (b)
Hdac4 controls chondrocyte hypertrophy by interacting with and
inhibiting the activity of Runx2 and Mef2c (Vega et al., 2004;
Arnold et al., 2007), and (c) our observation that DaCaMKII
modulates Mef2c as well as Runx2 activity, we addressed whether
DaCaMKII also physically interacts with Hdac4 or whether
it alters its repressive activity. For this, HEK293 cells were
co-transfected with FLAG::Hdac4 and DaCaMKII::GFP. Co-IP
studies with GFP-coupled magnetic beads revealed no physical
interaction for Hdac4 in the pull-down lysate (Figure 2B).
Luciferase assays on primary chondrocytes transfected with
MEF2-luc, Mef2c and Hdac4 resulted in the inhibition of Mef2
activity. Yet, this inhibitory effect was not altered by the addition
of increasing amounts of DaCaMKII (Figure 2C). This suggests
that the DaCaMKII does not modulate Hdac4 activity. In essence,
our results show that the activated form of CaMKII positively
influences the activity of the transcription factors Mef2c and to
a lesser extent Runx2 activity and that this effect is probably
not mediated via an inhibitory effect on Hdac4. Furthermore,
CaMKII physically interacts with Mef2c suggesting that it may
possibly modulate its transcriptional activity by phosphorylation.
In Vivo: Generation of Chondrocyte
Specific Transgenic Mice
In order to determine the in vivo role of CaMKII modulation
in mouse endochondral ossification, we employed a transgenic
approach using the Col2a1 promoter/enhancer element to drive
transgene expression in chondrocytes (Figures 3A,B). From
previous studies in the chicken we knew that eGFP tagged
transgenes are functional (Taschner et al., 2008). Hence, in order
to visualize transgene expression and to facilitate the distinction
between heterozygous and homozygous embryos, eGFP tagged
transgenes were used. For the DaCaMKII::eGFP construct
two independent transgenic founder lines (Tg1 and Tg2-
DaCaMKII) were established and for the eGFP::rKIIN construct
three independent founder lines were obtained (Tg1, Tg2,
and Tg3-rKIIN; Figures 3A,B). All founder lines transmitted
the transgene to the F1 generation. The transgenic lines
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FIGURE 2 | CaMKII physically interacts with Mef2c but not with HDAC4 and does not modulate Hdac4 activity. (A) Representative immunoblot of a
co-immunoprecipitation assay using GFP-magnetic beads and lysates from HEK293 cells co-transfected with Mef2c::Myc and CaMKII::GFP expression plasmids or
Mef2c::Myc and GFP expression plasmids analyzed with anti-myc tag antibody (n = 3). An interaction was observed in the Co-IP of Mef2c::Myc with CaMKII::GFP
(lane 2; indicated by the arrow at the hight of the Mef2c::Myc signal). The two unspecific signals due to the IgG heavy and light chains, are indicated by the stars.
Below the input for the Gfp- and Myc-tagged proteins used in the co-IP and the loading control with anti-P20 are shown. (B) Representative immunoblot of a
co-immunoprecipitation assay using GFP-magnetic beads on lysates from HEK293 cells co-transfected with FLAG::Hdac4 and CaMKII::GFP expression plasmids
analyzed with anti-myc tag antibody. No interaction was observed between DaCaMKII::eGFP and Hdac4 (lane 2), n = 2. (C) Primary chondrocytes from E13.5
wild-type appendicular skeletal elements were co-transfected with MEF2-luc, TK-renilla reporter and expression vectors encoding FLAG-Hdac4, and DaCaMKII
(increasing amounts). The ratio of luciferase activity with respect to control (Ctrl) is plotted in the bar graph: control (black bar), FLAG::Hdac4 (gray bar) and
FLAG::Hdac4 together with DaCaMKII (green bars), n = 3. n refers to the number of independent biological samples. ***p < 0.001. Error bars indicate ± SEM.
differed in the number of transgenes integrated in the genome
(Figure 3A). For a first characterization of the transgenic lines,
heterozygous transgenic mice of the independent founder lines
were intercrossed to isolate embryos at embryonic day (E) 15.5.
Contrary to our expectations, no obvious gross morphological
differences were detected within the offspring of the various
intercrosses (Figures 3C,D). Genotyping of the offspring was
performed examining the GFP intensity using a fluorescent
stereomicroscope and confirmed by conventional PCR-based
genotyping (Figures 3C,D; data not shown). Heterozygous and
homozygous transgenic embryos were classified based on the
fluorescence intensity (Figures 3C,D). As expected, GFP activity
was detected in the cartilaginous regions of the skeletal elements,
particularly visible in the skull and limbs at sites corresponding
toCol2a1 expression domains (Figures 3C,D; Cheah et al., 1991).
This was confirmed by ISHwith RNA antisense probes forCol2a1
and Gfp on adjacent sections of transgenic limbs (Figures 3E,F).
As expected, no Gfp signal was detected in humeri of non-
transgenic (wild-type) littermates (Figures 3E,F). These results
demonstrated that the transgene is indeed expressed in a Col2a1-
promoter/enhancer-dependent manner. Furthermore, the GFP
signal intensity in embryos as well as the Gfp ISH signal on
sections allowed us to distinguish heterozygous and homozygous
transgenic littermates.
In the chicken a subset of the chondrocytes that expressed
DaCaMKII prematurely differentiated into prehypertrophic and
subsequently into hypertrophic chondrocytes outside their
normal expression domains (Taschner et al., 2008; Li et al., 2011).
Hence, we performed ISH on E15.5 sections through the limbs
using Col2a1 as a marker for more immature chondrocytes, Ihh
as amarker for prehypertrophic cells, andCol10a1 as amarker for
hypertrophic cells. Yet, no expression of the maturation markers
Ihh or Col10a1 was observed outside their normal expression
domains and no obvious differences were observed with respect
to the individual domain sizes, distance between the domains,
or the expression levels of these three markers comparing
non-transgenic with heterozygous and homozygous DaCaMKII-
tg littermates (Figures 4A,B). Similar, negative results were
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FIGURE 3 | Overview of transgenic constructs and their chondrocyte-specific expression in transgenic embryos. (A,B) Schematic view of constructs
containing either the DaCaMKII::eGFP (A) or eGFP::rKIIN (B) downstream of the β-globin intron under the control of the Col2a1 promoter/enhancer region. The
number of independent transgenic lines achieved for each construct and the corresponding copy numbers in the genome are indicated below. (C,D) E15.5 littermates
from intercrosses of DaCaMKII::eGFP transgenic mice (C) and from intercrosses of eGFP::rKIIN transgenic mice (D) imaged under white light and fluorescence. The
GFP signal is detected in the cartilaginous skeletal elements of limbs, skull, and vertebrae. Note that the GFP signal is more intense in the homozygous (Tg/Tg)
embryos compared to heterozygous (Tg/+) littermates, while only weak auto-fluorescence is detected in the control (non-transgenic, +/+) littermates. Images were
taken at the same magnification under fluorescent stereomicroscope (Zeiss). (E,F) Non-radioactive Col2a1 and Gfp ISH on E15.5 humeri isolated from DaCaMKII-tg
mice (E) and isolated from rKIIN-tg mice (F) and corresponding control (non-transgenic, +/+) littermates showing that the Gfp riboprobe signal overlaps almost
completely with that of Col2a1. Signal intensity for the Gfp anti-sense riboprobe differs between heterozygous and homozygous transgenic embryos. SA, splice
acceptor site; pA, poly A.
obtained performing the analogous analysis on sections of E15.5
humeri from non-transgenic, heterozygous, and homozygous
rKIIN-tg littermates (Figures 4C,D). Here, we did not observe
an obvious delay in chondrocyte maturation, as one could have
expected based on the effect of rKIIN overexpression in chicken.
The final step in endochondral ossification is the remodeling
of the cartilage template into bone. Thus, in order to see whether
this remodeling process was altered, we analyzed the longitudinal
extension of the ossified zone by performing ISH analysis for the
osteoblastic markers collagen 1 (Col1a1), osteopontin (Opn), and
osteocalcin (Ocn) on sections of E18.5 DaCaMKII- and rKIIN-
tg humeri and corresponding non-transgenic littermates. No
significant alteration to the longitudinal extension of the ossified
zone for either of the three analyzed markers was observed when
comparing the humeri of the transgenic embryos expressing
either DaCaMKII (Figures 5A,B) or rKIIN with humeri of their
respective, non-transgenic controls (Figures 5C,D). Similar to
what we had observed at E15.5, no morphological alterations
with regard to the shape, organization or appearance of the
prehypertrophic and hypertrophic chondrocytes were detected
in the growth plates of the E18.5 DaCaMKII- and rKIIN-
tg humeri compared to their corresponding non-transgenic
littermate controls (Supplementary Figures 2A,B). In addition,
the total length, as well as the length of the mineralized region
was measured in alician blue/alizarin red stained humeri of
6-day-old pups. Here again, no differences regarding the two
parameters were observed in comparison to non-transgenic
littermate controls (Supplementary Figure 3).
Modulation of CaMKII Signaling Affects the
Onset of Chondrocyte Maturation
As there were no obvious effects visible in the older mouse
limbs, we addressed whether early steps of skeletogenesis would
potentially be affected. In the forelimb the anlagen of humerus,
radius and ulna are visible at E11.5. At this stage the cells
in the center of the humerus begin to express Ihh (data not
shown), while they start to express Col10a1 around E12.5.
In humeri of E12.5 DaCaMKII transgenic limbs the marker
for prehypertrophic chondrocytes, Ihh, was expressed in a
slightly broader domain compared to non-transgenic, control
littermates (Figures 6A–C). The effect was more prominent in
humeri of homozygous (6/8) than heterozygous (8/11). When we
analyzed the expression of Col10a1, as a marker for hypertrophic
chondrocyte differentiation, weak Col10a1 expression was first
detected in the humerus at E12.5-E13.0 in wild-type limbs. In
the transgenic specimens, in which we had observed a broadend
Ihh domain we noticed on adjacent sections a more intense
staining for Col10a1 in a broader domain (Figure 6D). Again
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FIGURE 4 | Modulation of CaMKII activity has no effect on the progression of chondrocyte maturation. (A,C) Analysis of E15.5 DaCaMKII (A) and rKIIN (C)
transgenic and respective control (non-transgenic) littermate humeri. (A) ISH for Col2a1, Ihh, and Col10a1 on sections of E15.5 humeri from control, DaCaMKII hetero-
(Tg/+) and homozygous (Tg/Tg) littermates, showing no major alterations in the expression levels or the sizes of the expression domains of these three markers.
(B) Quantification of the relative distance between the Col2a1, Ihh, and Col10a1 domains revealed no significant differences for these markers. (C) ISH for Col2a1, Ihh,
and Col10a1 on sections of E15.5 humeri from control, rKIIN hetero- (Tg/+) and homozygous (Tg/Tg) littermates revealed no obvious alterations. (D) Quantification of
the relative distance between the Col2a1, the Ihh, and the Col10a1 domains confirmed the absence of a significant difference. The distance between the domains in
control was set to 100%. (B,D) The number of independent biological samples is referred to by n. The results are not significant. Error bars indicate ± SEM.
the effect was more obvious in the homozygous specimens.
Next we asked whether the increased Col10a1 expression was
accompanied by the histological appearance of hypertrophic
chondrocytes. For this, we examined E12.5 and E13.5 limbs
by alcian blue staining. On alcian blue stained sections, the
hypertrophic chondrocytes within the cartilage elements appear
lighter in color due to their increase in size and vacuolization.
Histological examination of E12.5 humeri (n = 2) revealed
no apparent signs of hypertrophic chondrocyte differentiation
in the transgenic limbs (Supplementary Figure S4A). In E13.5
DaCaMKII-tg humeri, a moderate size increase of the zone of
hypertrophic chondrocytes was detected compared to the non-
transgenic control (Figure 6E, n= 3). Consistent with the in vivo
ISH results, qPCR analysis of material from E12.5 DaCaMKII
transgenic and non-transgenic control limbs revealed an increase
in Ihh and Col10a1 expression levels in the transgenic limbs in
comparison to the control (Figure 6F). These results suggest that
the onset of chondrocyte maturation is slightly accelerated in the
transgenic limbs.
We then analyzed rKIIN transgenic limbs at equivalent stages.
At E12.5, no obvious differences were detected with respect
to the size or intensity of the Ihh expression domains between
transgenic and non-transgenic embryos (Supplementary Figure
S4B). However, at E13.5 the two expression domains of Ihh
were not yet separated in the humeri of homozygous transgenic
animals and still closer together in the heterozygous transgenic
animals compared to non-transgenic littermate controls
(Figure 6I). Furthermore, the Col10a1 expression domain
was reduced in size in the humeri of the transgenic animals
compared to non-transgenic littermate controls (Figure 6J).
Together, his suggests that the onset of chondrocyte maturation
is slightly delayed when CaMKII signaling is antagonized. Again,
the effect was more pronounced in homozygous (9/9) than in
heterozygous transgenic specimens (11/13) compared to non-
transgenic specimens (Figures 6I,J). Histological examination
of alcian blue stained E13.5 humeri confirmed that the decrease
in the size of the Col10a1 expression domain in homo- and
heterozygous humeri was associated with reduced hypertrophic
chondrocyte differentiation (Figure 6K). Quantification of Ihh
and Col10a1 expression levels by qPCR using material from
E13.5 forelimbs corroborated the dose-dependent effects of
CaMKII-signaling inhibition, which was statistically significant
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FIGURE 5 | Modulation of CaMKII activity does not affect the endochondral ossification process. (A,C) Representative images of ISH for the osteoblastic
markers Col1a1, Opn, and Ocn on sections through E18.5 humeri of DaCaMKII- (A) and rKIIN-tg (C), and their respective littermate, non-transgenic controls. (B,D)
Bar diagram representing relative size (longitudinal expansion) of the Col1a1, Opn, and Ocn expressing domains (zone of ossification) in the humeri of control
(non-transgenic), DaCaMKII- (B) and rKIIN-tg (D) E18.5 embryos. (B,D) The length between the domains in the control humeri was set to 100% to account for
developmental differences between litters. n refers to the number of independent biological samples. *p < 0.05, n.s., not significant. Error bars indicate ± SEM.
with respect to Col10a1 expression (Figure 6L). Together, our
results suggest that modulation of CaMKII signaling in the
mouse affects the onset of chondrocyte maturation during the
early stages of endochondral ossification.
ISH with a Gfp riboprobe confirmed transgene expression at
all stages examined and at least according to the ISH transgene
expression was not silenced after E13.5 (Supplementary Figure
5). In order to determine why the expression of the DaCaMKII
and rKIIN-transgenes may not lead to a major phenotype at
later stages we examined the transgene expression level in the
two DaCaMKII-transgenic lines, DaCaMKII-Tg1 (1 copy) and
DaCaMKII -Tg2 (19 copies), using qPCR and RNA isolated from
the chondrogenic elements of E12.5 limbs. Transgene expression
levels were estimated by comparing the DaCaMKII::GFP
transgene expression level to the endogenous expression levels
of the four CaMKII isoforms and the levels were normalized
to the Camk2g expression level. Here, we noticed that the
transgene expression levels in the Tg1 line were similar to the
Camk2a endogenous levels in the wild-type control. Yet, they
were lower than the endogenous expression levels of the γ and
δ isoforms. Interestingly, the Camk2a expression levels were
increased significantly in the transgenic skeletal elements of the
DaCaMKII-Tg1 line. In contrast, transgene expression level in
the Tg2 line with 19 copies did not even reach the Camk2a
endogenous levels. As such, the transgene copy number did
not correlate with the transgene expression levels in the two
independent lines (Supplementary Figures 6A,B).
DISCUSSION
Based on previous work in chicken it has been proposed that
activation of the endogenous CaMKII activity controls the
onset of the prehypertrophic and hypertrophic chondrogenic
program. In proliferating chondrocytes, the phosphorylated
form of CaMKII is not detectable and possibly constantly
dephosphorylated under the influence of PTHrP signaling (Li
et al., 2011). As a consequence, the phosphorylated form of
CaMKII is limited to the prehypertrophic and hypertrophic
chondrocytes in chicken and mouse (Li et al., 2011). In the
chicken, ectopic expression of an activated form of CaMKII,
was able to override the endogenous CaMKII activity or lack
thereof in proliferating chondrocytes and led to premature and
ectopic activation of the prehypertrophic/hypertrophic program
in cells outside of the normal maturation zones (Taschner et al.,
Frontiers in Cell and Developmental Biology | www.frontiersin.org 9 March 2017 | Volume 5 | Article 20
Amara et al. CaMKII Signaling in Mouse Skeletogenesis
FIGURE 6 | Modulation of CaMKII signaling affects the onset of chondrocyte maturation in early skeletal development. (A–D) Representative, alternating
sections through humeri of E12.5 control (non-transgenic, +/+), hetero- (Tg/+), and homozygous (Tg/Tg) DaCaMKII-tg littermates. (A) Gfp ISH revealing transgene
expression in heterozygous and homozygous animals but not in non-transgenic littermate controls. (B) Col2a1 ISH confirming that the transgene expression is
restricted to the Col2a1 positive domain. (C) Ihh ISH defining the prehypertrophic zone, which is enlarged in the homozygous and heterozygous transgenic embryos.
(D) Col10a1 ISH marking the onset of hypertrophic chondrocyte differentiation. Col10a1 expression was more intense in the transgenic embryos compared to control
(non-transgenic) littermates. (E) Alcian blue/eosin stained representative images of sections through E13.5 humeri of control (non-transgenic; +/+), hetero- (Tg/+),
and homozygous (Tg/Tg) DaCaMKII-tg embryos. Images below show magnifications of the boxed areas in the panel above. Due to their increase in volume and
vacuolization of the cells, the hypertrophic chondrocytes appear whiter. The region of hypertrophy is enlarged in the transgenic humeri compared to wild-type
littermate control. (F) qPCR analysis for Ihh and Col10a1 normalized to Gapdh and Actb using material from E12.5 control, hetero- and homozygous DaCaMKII-tg
forelimbs reveals a dose-dependent increase in the expression of these two genes. Gene expression levels are plotted relative to control. (G–J) Representative,
alternating sections through humeri of E12.5 (G,H) and E13.5 (I,J) control (non-transgenic; +/+) and hetero- (Tg/+), and homozygous (Tg/Tg) rKIIN-tg littermates. (G)
Gfp ISH revealing transgene expression in heterozygous and homozygous animals but not in non-transgenic littermate controls. (H) Col2a1 ISH confirming that the
transgene expression is restricted to the Col2a1 positive domain. (I) Ihh ISH defining the prehypertrophic zone, which is reduced in a transgene dose-dependent
manner in the hetero- and homozygous transgenic embryos. (J) Col10a1 ISH defining the hypertrophic zone, showing that hypertrophic differentiation is even more
delayed. (K) Histological alcian blue/eosin stained representative images of sections from control, hetero- and homozygous rKIIN embryos: here, fewer and smaller
hypertrophic, whiter cells are visible in hetero- and homozygous transgenic humeri compared to wild-type littermate controls. (L) qPCR analysis for Ihh and Col10a1
normalized to Gapdh and Actb using material from E13.5 control, hetero- and homozygous rKIIN-tg forelimbs revealing a dose-dependent reduction in the expression
of Ihh and Col10a1. Gene expression levels are plotted relative to control. (F,L) n refers to the number of independent biological samples. **p < 0.01, ***p < 0.001,
n.s., not significant. Error bars indicate ± SEM.
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2008; Li and Dudley, 2009; Li et al., 2011). In mouse long
bone development, the phenotypic effects of CaMKII activation
in proliferating, type II collagen-expressing chondrocytes were
very mild and in vivo, effects could only be detected
developmentally around the onset of chondrocyte hypertrophy
at E12.5–E13.5. Here, our data suggest that in agreement with
previous findings in chicken, DaCaMKII in mouse activated
the prehypertrophic/hypertrophic program prematurely at early
stages of endochondral ossification, while down-regulation of
endogenous CaMKII activity interfered with the onset of the
prehypertrophic and hypertrophic program. Interestingly, the
phenotypic changes caused by CaMKII activity modulation at the
onset of chondrocyte maturation did not accumulate over time
despite the fact that the transgene was continuously expressed
in type II collagen-producing chondrocytes (Supplementary
Figure 5). Yet, in contrast to the overexpression experiments
in chicken, no premature maturation of chondrocytes outside
their normal maturation zones or shortening of the limbs
was observed. Hence, the phenotypic consequences of ectopic
activation of CaMKII are quite distinct between chicken and
mouse (Taschner et al., 2008; Li and Dudley, 2009; Li et al.,
2011). Possible explanations for the phenotypic discrepancies
between chicken and mouse could be that on the one hand
in the chicken not only chondrocytes also the soft tissue is
infected and that this could contribute to the phenotype. On
the other hand, it is likely that the retroviral driven expression
levels of the transgenes were much higher in chicken. For
retroviral driven transgenes over 100-fold expression levels have
been reported (Geetha-Loganathan et al., 2014; Nimmagadda
et al., 2015). In the mouse, we did not detect phenotypic
differences between the independent transgenic lines despite
the fact that they varied in copy numbers (Figure 3A), which
can be explained by the fact that transgene expression levels
were similarly low in both cases (about one-fold of the Camk2a
endogenous levels; Supplementary Figure 6). Hence, the lack of
a major phenotype in the transgenic mice may be associated
with the relatively low transgene expression levels compared
to the expression levels that have been reached by retroviral
expression in the chicken. Although, of course, the actual levels
of retroviral-driven DaCaMKII transgene expression were not
determined in the chicken experiments performed previously
(Taschner et al., 2008; Li and Dudley, 2009; Li et al., 2011). A
possible explanation for the observed transient phenotype at the
early stages of skeletal development maybe that the onset of
chondrocyte maturation may present a window of opportunity
for the transgenes to excert a mild effect accelerating, respectively
delaying chondrocyte maturation. And that this effect is later
on compensated as the chondrocyte maturation program comes
under the transcriptional control of many regulatory factors and
feed back mechanisms as development progresses (Hartmann,
2009; Kozhemyakina et al., 2015).
At the molecular level, we observed in vitro that CaMKII
robustly affects the transcriptional activity of the transcription
factor Mef2c and to a lesser extent also Runx2 transcriptional
activity. Mef2c and Runx2 start to be expressed as the
chondrocytes undergo hypertrophy (Arnold et al., 2007). Mef2c
and Runx2 activity are both negatively regulated by the class II
histone deacetylase HDAC4 (Vega et al., 2004; Kozhemyakina
et al., 2009; Correa et al., 2010). In vascular smooth muscle cells,
CaMKIIdelta2 regulates Mef2 transcriptional activity through
HDAC4/5 (Ginnan et al., 2012). Yet, our results indicate that
activated CaMKII increases Mef2c activity by an HDAC4-
independent mechanism. As the activated form of CaMKII
physically interacts with Mef2c, the underlying mechanism
may involve phosphorylation of Mef2c protein by CaMKII. In
different cell types other kinases, such as p38 MAPK and ERK5,
have also been shown to phosphorylate Mef2c enhancing its
transcriptional activity (Han et al., 1997; Kato et al., 1997).
Yet, there is the obvious discrepancy between the in vitro
results where a robust stimulatory effect onMef2c transcriptional
activity was observed and the subtle in vivo effects. For the in vitro
luciferase experiments an expression vector was used that drives
DaCaMKII expression under the control of the CMV promoter,
which drives high levels of expression in mammalian cells. The
high transgene expression levels in vitro (Supplementary Figure
1) may be an explaination for the strong in vitro effect on
Mef2c activity and in contrast to the only mild effect in vivo
where transgene expression levels were at least a 100-fold lower.
Furthermore, Li and colleagues proposed that the endogenous
CaMKII activity is opposed by an inhibitory gradient, which is
under the control of PTHrP signaling (Li et al., 2011). PTHrP
signaling via cAMP and protein kinase A negatively regulates
chondrocyte hypertrophy through HDAC4 mediated inhibition
of Mef2c activity (Kozhemyakina et al., 2009). Yet, even in vitro,
DaCaMKII signaling was not able to overcome or to partially
revert the effect of HDAC4 on Mef2c activity (Figure 2C). The
PTHrP expression itself is under the regulatory control of Ihh-
signaling (Vortkamp et al., 1996; St-Jacques et al., 1999). As
such the slightly increased Ihh expression observed in the E12.5
DaCaMKII transgenic limbs may upregulate PTHrP signaling
and counteract a possibly direct, positive effect of DaCaMKII
on the Mef2c activity via HDAC4. Hence, one possible scenario
may be that increased levels of PTHrP signaling override the
activation of Mef2c by DaCaMKII at later stages of development.
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